メールサービス キャンペーン : 期間中に新規登録や配信希望カテゴリの変更等をされた方に、ご用意した無料レポートを提供しております。 新規登録 / 登録内容変更

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

蛍光in-situハイブリダイゼーションプローブ (FISHプローブ) 市場分析:エンドユース別 (研究、臨床、コンパニオン診断) 、RNAタイプ別 (mRNA、miRNA) 、用途別、ISHプローブ技術別、および2022年までのセグメント予測

Fluorescent In Situ Hybridization Probe (FISH Probe) Market Analysis By End Use (Research, Clinical, Companion Diagnostics), By Type Of RNA (mRNA, miRNA), By Application, By ISH Probe Technology, To 2022

発行 Grand View Research, Inc. 商品コード 355227
出版日 ページ情報 英文 82 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.90円で換算しております。
Back to Top
蛍光in-situハイブリダイゼーションプローブ (FISHプローブ) 市場分析:エンドユース別 (研究、臨床、コンパニオン診断) 、RNAタイプ別 (mRNA、miRNA) 、用途別、ISHプローブ技術別、および2022年までのセグメント予測 Fluorescent In Situ Hybridization Probe (FISH Probe) Market Analysis By End Use (Research, Clinical, Companion Diagnostics), By Type Of RNA (mRNA, miRNA), By Application, By ISH Probe Technology, To 2022
出版日: 2015年11月03日 ページ情報: 英文 82 Pages
概要

世界の蛍光in-situハイブリダイゼーションプローブ (FISHプローブ) 市場は、2022年までに18億3,000万米ドルに達すると予測されています。癌や遺伝子異常などの細胞遺伝学的奇病の罹患率上昇とともに、迅速かつ正確、敏感な予後診断技術の需要の高まりが同市場の成長を牽引しています。さらに、新規の疾患固有のFISHプローブバイオマーカーの開発などの取組みが進められていることも、市場の成長を促進する要因となっています。

当レポートでは、世界のFISHプローブ市場の現状と2022年までの成長見通し、エンドユース別、RNAタイプ別、用途別、技術別動向、および主要企業のプロファイルなどをまとめています。

第1章 調査方法と調査範囲

第2章 エグゼクティブサマリー

第3章 業界見通し

  • 市場セグメンテーション
  • 市場規模と成長見通し
  • 市場動向
    • 促進因子
    • 阻害因子
  • 市場の機会
  • 業界分析:ポーターズ
  • PESTEL分析
  • FISHプローブ技術開発分析
  • FISH技術の比較分析

第4章 エンドユース別市場見通し

  • エンドユース別収益シェア
  • 研究
  • 臨床
  • コンパニオン診断

第5章 RNA別見通し

  • RNA別市場シェア
  • mRNA
  • miRNA
  • その他

第6章 用途別見通し

  • 用途別市場シェア
  • 癌診断
  • 遺伝子疾患
  • その他

第7章 技術別見通し

  • 技術別市場シェア
  • FISH
  • CISH
  • DISH

第8章 地域別見通し

  • 地域別市場シェア
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合環境

  • Mirus Bio LLC
  • Life Science Technologies
  • PerkinElmer Inc
  • BioDot Inc.
  • Horizon Diagnostics
  • Sigma-Aldrich Corporation
  • Agilent Technologies
  • Abnova Corporation
  • Biosearch Technologies Inc.
  • Genemed Biotechnologies, Inc.
  • AffymetrixPanomics
  • F. Hoffman-La Roche AG - Life Science
  • Oxford Gene Technology
  • Bio Care Medical, LLC
  • EXIQON
  • GSP Research Institute Co., Ltd.

図表

目次
Product Code: 978-1-68038-596-0

The global FISH probe market is expected to reach USD 1.73 billion by 2022, according to a new report by Grand View Research, Inc. Rising prevalence rate of disorders with cytogenetic base such as cancer and genetic abnormalities coupled with demand for rapid, accurate & sensitive prognosis techniques for disease validation are the key factors propelling growth of FISH probe in coming years. In addition, increasing R&D initiatives by industry players for development of novel, disease specific FISH probes biomarkers and pipeline products awaiting approval are other factors expected to boost industry growth.

Technological advancement in chromogenic in situ hybridization (CISH) such as higher storage time for analyzed samples for long duration studies is expected to boost penetration of CISH probe in near future.

Further key findings from the report suggest:

CISH is expected to be the fastest growing technology segment and is expected to grow at a lucrative CAGR of over 7.0% by 2022. Samples using CISH can be detected through bright field microscope and are thus less expensive than FISH. Strong signal quality for longer period of time is a major advantage of CISH over other methods.

Companion diagnostics is used in personalized medicine and it includes medical decision, products and practices based on patient's genetic, clinical, and genomic information. In oncology major companion diagnostics are based on FISH owing to higher reliability, sensitivity, accuracy, and procedure reproducibility, which are less affected by analytical variables and tissue fixation as compared to immunohistochemistry.

Increasing demand in personalized medicine is a key factor expected to assist the companion diagnostics market register the fastest growth during the forecast period.

mRNA dominated the type of RNA market, with revenue valued at over USD 300.0 million in 2014, owing to increased penetration and effective detection and validation of cytogenetic diseases.

miRNA is expected to be the fastest growing RNA segment and is expected to grow at a CAGR of above 7.0% by 2022. The miRNA market is driven by factors such as the increasing R&D for development of miRNA probes and growing application of miRNA as a prognostic tool in cancer.

Flow FISH is used for approximate detection of telomere length in case of large population studies. It is considered to be a modification of QFISH, but has been proved to give high through output than other counterparts. All the aforementioned facts are responsible for the lucrative growth of this segment over the forecast period. miRCURY LNA microRNA detection probes for ISH by Exiqon and PrimeFlow RNA assay by Affymetrix are used in RNA research and quantification.

North America was the largest regional FISH probe market and was valued at over USD 400.0 million in 2014. The region's market position is attributed to factors such as presence of well established healthcare system and increasing demand for accurate and rapid molecular cytogenetics techniques.

The Asia Pacific FISH probe market is expected to exhibit lucrative growth of 9.0% over the forecast period due to rising per capita healthcare expenditure, improving healthcare facilities, and demand for IVD testing for disease detection. Additionally, increasing R&D activities pertaining to cancer diagnostics and investment by private & government sector into biotech industry in this region are the factors responsible for the growth.

Key players of the FISH probe market include Oxford Gene Technology, Mirus Bio LLC, Agilent Technologies, Perkin Elmer Inc., Genemed Biotechnologies Inc., Horizon Diagnostics, BioDot Inc., Sigma Aldrich, Life Science Technologies, GSP Research Institute Co., Ltd, Abnova Corporation, Biosearch Technologies, F Hoffman La Roche AG, Bio Care Medical LLC, EXIQON, and Affymetrix Panomics.

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Scope & Assumptions
  • 1.3. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. FISH Probe - Industry Snapshot and Key Buying Criteria, 2012 - 2022

Chapter 3. FISH Probe Industry Outlook

  • 3.1. FISH probe: Market segmentation
  • 3.2. FISH probemarket size and growth prospects
  • 3.3. FISH probe: Market dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Key opportunities prioritized
  • 3.5. Industry analysis - Porter's
  • 3.6. FISH probe market: PESTEL analysis, 2014
  • 3.7. FISH Probe Technology Development Analysis
    • 3.7.1. FISH probe technology development analysis
  • 3.8. Comparative Analysis of FISH Techniques

Chapter 4. FISH Probe End-use Outlook

  • 4.1. FISH probe market share, by end-use, 2014& 2022
  • 4.2. Research
    • 4.2.1. Research market estimates and forecasts, 2012 - 2022 (USD Million)
  • 4.3. Clinical
    • 4.3.1. Clinical market estimates and forecasts, 2012 - 2022 (USD Million)
  • 4.4. Companion diagnostics
    • 4.4.1. Companion diagnostics market estimates and forecasts, 2012 - 2022 (USD Million)

Chapter 5. FISH Probe RNA Outlook

  • 5.1. FISH probe market share, by RNA, 2014& 2022
  • 5.2. mRNA
    • 5.2.1. mRNA market estimates and forecasts, 2012 - 2022 (USD Million)
  • 5.3. miRNA
    • 5.3.1. miRNA market estimates and forecasts, 2012 - 2022 (USD Million)
  • 5.4. Other
    • 5.4.1. Other market estimates and forecasts, 2012 - 2022 (USD Million)

Chapter 6. FISH Probe Application Outlook

  • 6.1. FISH probemarket share, by application, 2014& 2022
  • 6.2. Cancer diagnostics
    • 6.2.1. Cancer diagnostics market estimates and forecasts, 2012 - 2022 (USD Million)
    • 6.2.2. Lung cancer
      • 6.2.2.1. Lung cancer market estimates and forecasts, 2012 - 2022 (USD Million)
    • 6.2.3. Breast cancer
      • 6.2.3.1. Breast cancer market estimates and forecasts,2012 - 2022 (USD Million)
    • 6.2.4. Other
      • 6.2.4.1. Other market estimates and forecasts,2012 - 2022 (USD Million)
  • 6.3. Genetic diseases
    • 6.3.1. Genetic diseases market estimates and forecasts, 2012 - 2022 (USD Million)
  • 6.4. Other
    • 6.4.1. Other market estimates and forecasts, 2012 - 2022 (USD Million)

Chapter 7. FISH Probe Technology Outlook

  • 7.1. FISH probe market share, by technology, 2014& 2022
  • 7.2. FISH
    • 7.2.1. FISH market estimates and forecasts, 2012 - 2022 (USD Million)
    • 7.2.2. Q FISH
      • 7.2.2.1. Q FISH market estimates and forecasts, 2012 - 2022 (USD Million)
    • 7.2.3. Flow-FISH
      • 7.2.3.1. Flow-FISH market estimates and forecasts, 2012 - 2022 (USD Million)
    • 7.2.4. Other
      • 7.2.4.1. Other market estimates and forecasts,2012 - 2022 (USD Million)
  • 7.3. CISH
    • 7.3.1. CISH market estimates and forecasts, 2012 - 2022 (USD Million)
  • 7.4. DISH
    • 7.4.1. DISH market estimates and forecasts, 2012 - 2022 (USD Million)

Chapter 8. FISH Probe Regional Outlook

  • 8.1. FISH probemarket share, by region, 2014& 2022
  • 8.2. North America
    • 8.2.1. North America FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)
  • 8.3. Europe
      • 8.3.1.1. Europe FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK. FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany. FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)
    • 8.3.4. France
      • 8.3.4.1. France. FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)
  • 8.4. Asia Pacific
      • 8.4.1.1. Asia Pacific FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan. FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)
    • 8.4.3. China
      • 8.4.3.1. China. FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)
    • 8.4.4. India
      • 8.4.4.1. India. FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)
  • 8.5. Latin America
      • 8.5.1.1. Latin America FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)
    • 8.5.2. Mexico
      • 8.5.2.1. Mexico. FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Brazil. FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)
  • 8.6. MEA
      • 8.6.1.1. MEA FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa. FISH probemarket estimates and forecasts, 2012 - 2022(USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Mirus Bio LLC
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Strategic Initiatives
  • 9.2. Life Science Technologies
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Strategic Initiatives
  • 9.3. PerkinElmer Inc
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Strategic Initiatives
  • 9.4. BioDot Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Strategic Initiatives
  • 9.5. Horizon Diagnostics
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Strategic Initiatives
  • 9.6. Sigma-Aldrich Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Strategic Initiatives
  • 9.7. Agilent Technologies
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Strategic Initiatives
  • 9.8. Abnova Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Strategic Initiatives
  • 9.9. Biosearch Technologies Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Strategic Initiatives
  • 9.10. Genemed Biotechnologies, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Strategic Initiatives
  • 9.11. AffymetrixPanomics
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Strategic Initiatives
  • 9.12. F. Hoffman-La Roche AG - Life Science
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Strategic Initiatives
  • 9.13. Oxford Gene Technology
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Strategic Initiatives
  • 9.14. Bio Care Medical, LLC
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Strategic Initiatives
  • 9.15. EXIQON
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Strategic Initiatives
  • 9.16. GSP Research Institute Co., Ltd.
    • 9.16.1. Company Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Strategic Initiative

List of Tables

  • TABLE 1: FISH probe- Industry Snapshot & Key Buying Criteria, 2012 - 2022
  • TABLE 2: Global FISH probe market, by end use, 2012 - 2022 (USD Million)
  • TABLE 3: Global FISH probe market, by type of RNA, 2012 - 2022
  • TABLE 4: Global FISH probe market, by application, 2012 - 2022
  • TABLE 5: Global FISH probe market, by cancer diagnostics, 2012 - 2022
  • TABLE 6: Global ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 7: Global FISH probe market, by types, 2012 - 2022 (USD Million)
  • TABLE 8: Global FISH probe market, by region, 2012 - 2022 (USD Million)
  • TABLE 9: FISH probe- Key market driver analysis
  • TABLE 10: FISH probe market - Key market restraint analysis
  • TABLE 11: U.S. FISH probe market, by end use , 2012 - 2022 (USD Million)
  • TABLE 12: U.S. FISH probe market, by type of RNA, 2012 - 2022 (USD Million)
  • TABLE 13: U.S. FISH probe market, by application, 2012 - 2022 (USD Million)
  • TABLE 14: U.S. FISH probe market, by cancer diagnostics, 2012 - 2022 (USD Million)
  • TABLE 15: U.S. ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 16: U.S. FISH probe market, by type, 2012 - 2022 (USD Million)
  • TABLE 17: U.S. FISH probe market, by end use , 2012 - 2022 (USD Million)
  • TABLE 18: U.S. FISH probe market, by type of RNA, 2012 - 2022 (USD Million)
  • TABLE 19: U.S. FISH probe market, by application, 2012 - 2022 (USD Million)
  • TABLE 20: U.S. FISH probe market, by cancer diagnostics, 2012 - 2022 (USD Million)
  • TABLE 21: U.S. ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 22: U.S. FISH probe market, by type, 2012 - 2022 (USD Million)
  • TABLE 23: Canada FISH probe market, by end use , 2012 - 2022 (USD Million)
  • TABLE 24: Canada FISH probe market, by type of RNA, 2012 - 2022 (USD Million)
  • TABLE 25: Canada FISH probe market, by application, 2012 - 2022 (USD Million)
  • TABLE 26: Canada FISH probe market, by cancer diagnostics, 2012 - 2022 (USD Million)
  • TABLE 27: Canada ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 28: Canada FISH probe market, by type, 2012 - 2022 (USD Million)
  • TABLE 29: Europe FISH probe market, by end use , 2012 - 2022 (USD Million)
  • TABLE 30: Europe FISH probe market, by type of RNA, 2012 - 2022 (USD Million)
  • TABLE 31: Europe FISH probe market, by application, 2012 - 2022 (USD Million)
  • TABLE 32: Europe FISH probe market, by cancer diagnostics, 2012 - 2022 (USD Million)
  • TABLE 33: Europe ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 34: Europe FISH probe market, by type, 2012 - 2022 (USD Million)
  • TABLE 35: UK FISH probe market, by end use , 2012 - 2022 (USD Million)
  • TABLE 36: UK FISH probe market, by type of RNA, 2012 - 2022 (USD Million)
  • TABLE 37: UK FISH probe market, by application, 2012 - 2022 (USD Million)
  • TABLE 38: UK FISH probe market, by cancer diagnostics, 2012 - 2022 (USD Million)
  • TABLE 39: UK ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 40: UK FISH probe market, by type, 2012 - 2022 (USD Million)
  • TABLE 41: Germany FISH probe market, by end use , 2012 - 2022 (USD Million)
  • TABLE 42: Germany FISH probe market, by type of RNA, 2012 - 2022 (USD Million)
  • TABLE 43: Germany FISH probe market, by application, 2012 - 2022 (USD Million)
  • TABLE 44: Germany FISH probe market, by cancer diagnostics, 2012 - 2022 (USD Million)
  • TABLE 45: Germany ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 46: Germany FISH probe market, by type, 2012 - 2022 (USD Million)
  • TABLE 47: Asia Pacific FISH probe market, by end use , 2012 - 2022 (USD Million)
  • TABLE 48: Asia Pacific FISH probe market, by type of RNA, 2012 - 2022 (USD Million)
  • TABLE 49: Asia Pacific FISH probe market, by application, 2012 - 2022 (USD Million)
  • TABLE 50: Asia Pacific FISH probe market, by cancer diagnostics, 2012 - 2022 (USD Million)
  • TABLE 51: Asia Pacific ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 52: Asia Pacific FISH probe market, by type, 2012 - 2022 (USD Million)
  • TABLE 53: Japan FISH probe market, by end use , 2012 - 2022 (USD Million)
  • TABLE 54: Japan FISH probe market, by type of RNA, 2012 - 2022 (USD Million)
  • TABLE 55: Japan FISH probe market, by application, 2012 - 2022 (USD Million)
  • TABLE 56: Japan FISH probe market, by cancer diagnostics, 2012 - 2022 (USD Million)
  • TABLE 57: Japan ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 58: Japan FISH probe market, by type, 2012 - 2022 (USD Million)
  • TABLE 59: China FISH probe market, by end use , 2012 - 2022 (USD Million)
  • TABLE 60: China FISH probe market, by type of RNA, 2012 - 2022 (USD Million)
  • TABLE 61: China FISH probe market, by application, 2012 - 2022 (USD Million)
  • TABLE 62: China FISH probe market, by cancer diagnostics, 2012 - 2022 (USD Million)
  • TABLE 63: China ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 64: China FISH probe market, by type, 2012 - 2022 (USD Million)
  • TABLE 65: India FISH probe market, by end use , 2012 - 2022 (USD Million)
  • TABLE 66: India FISH probe market, by type of RNA, 2012 - 2022 (USD Million)
  • TABLE 67: India FISH probe market, by application, 2012 - 2022 (USD Million)
  • TABLE 68: India FISH probe market, by cancer diagnostics, 2012 - 2022 (USD Million)
  • TABLE 69: India ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 70: India FISH probe market, by type, 2012 - 2022 (USD Million)
  • TABLE 71: Latin America FISH probe market, by end use , 2012 - 2022 (USD Million)
  • TABLE 72: Latin America FISH probe market, by type of RNA, 2012 - 2022 (USD Million)
  • TABLE 73: Latin America FISH probe market, by application, 2012 - 2022 (USD Million)
  • TABLE 74: Latin America FISH probe market, by cancer diagnostics, 2012 - 2022 (USD Million)
  • TABLE 75: Latin America ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 76: Latin America FISH probe market, by type, 2012 - 2022 (USD Million)
  • TABLE 77: Mexico FISH probe market, by end use , 2012 - 2022 (USD Million)
  • TABLE 78: Mexico FISH probe market, by type of RNA, 2012 - 2022 (USD Million)
  • TABLE 79: Mexico FISH probe market, by application, 2012 - 2022 (USD Million)
  • TABLE 80: Mexico FISH probe market, by cancer diagnostics, 2012 - 2022 (USD Million)
  • TABLE 81: Mexico ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 82: Mexico FISH probe market, by type, 2012 - 2022 (USD Million)
  • TABLE 83: Brazil FISH probe market, by end use , 2012 - 2022 (USD Million)
  • TABLE 84: Brazil FISH probe market, by type of RNA, 2012 - 2022 (USD Million)
  • TABLE 85: Brazil FISH probe market, by application, 2012 - 2022 (USD Million)
  • TABLE 86: Brazil FISH probe market, by cancer diagnostics, 2012 - 2022 (USD Million)
  • TABLE 87: Brazil ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 88: Brazil FISH probe market, by type, 2012 - 2022 (USD Million)
  • TABLE 89: MEA FISH probe market, by end use , 2012 - 2022 (USD Million)
  • TABLE 90: MEA FISH probe market, by type of RNA, 2012 - 2022 (USD Million)
  • TABLE 91: MEA FISH probe market, by application, 2012 - 2022 (USD Million)
  • TABLE 92: MEA FISH probe market, by cancer diagnostics, 2012 - 2022 (USD Million)
  • TABLE 93: MEA ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 94: MEA FISH probe market, by type, 2012 - 2022 (USD Million)
  • TABLE 95: South Africa FISH probe market, by end use , 2012 - 2022 (USD Million)
  • TABLE 96: South Africa FISH probe market, by type of RNA, 2012 - 2022 (USD Million)
  • TABLE 97: South Africa FISH probe market, by application, 2012 - 2022 (USD Million)
  • TABLE 98: South Africa FISH probe market, by cancer diagnostics, 2012 - 2022 (USD Million)
  • TABLE 99: South Africa ISH probe market, by technology, 2012 - 2022 (USD Million)
  • TABLE 100: South Africa FISH probe market, by type, 2012 - 2022 (USD Million)

List of Figures

  • FIG. 1: FISH probe: Market segmentation
  • FIG. 2: FISH probe market, 2014 - 2022 (USD Million)
  • FIG. 3: FISH probe: Market dynamics
  • FIG. 4: Key opportunities prioritized
  • FIG. 5: FISH probe market Porter's analysis
  • FIG. 6: FISH probe market PESTEL analysis
  • FIG. 7: FISH probe technology development analysis, 2014
  • FIG. 8: FISH probe revenue share by end use, 2014 & 2022
  • FIG. 9: Research market, 2012 - 2022 (USD Million)
  • FIG. 10: Clinical market, 2012 - 2022 (USD Million)
  • FIG. 11: Companion diagnostic market, 2012 - 2022 (USD Million)
  • FIG. 12: FISH probe market share by RNA, 2014 & 2022
  • FIG. 13: mRNA market, 2012 - 2022 (USD Million)
  • FIG. 14: miRNA market, 2012 - 2022 (USD Million)
  • FIG. 15: Other market, 2012 - 2022 (USD Million)
  • FIG. 16: FISH probe market share by application, 2014 & 2022
  • FIG. 17: Cancer diagnostics market, 2012 - 2022 (USD Million)
  • FIG. 18: Lung cancer market, 2012 - 2022 (USD Million)
  • FIG. 19: Breast cancer market, 2012 - 2022 (USD Million)
  • FIG. 20: Other market, 2012 - 2022 (USD Million)
  • FIG. 21: Genetic diseases market, 2012 - 2022 (USD Million)
  • FIG. 22: Other market, 2012 - 2022 (USD Million)
  • FIG. 23: FISH probe revenue share by technology, 2014 & 2022
  • FIG. 24: FISH market, 2012 - 2022 (USD Million)
  • FIG. 25: Q FISH market, 2012 - 2022 (USD Million)
  • FIG. 26: Flow FISH market, 2012 - 2022 (USD Million)
  • FIG. 27: Other FISH market, 2012 - 2022 (USD Million)
  • FIG. 28: CISH market, 2012 - 2022 (USD Million)
  • FIG. 29: DISH market, 2012 - 2022 (USD Million)
  • FIG. 30: FISH probemarket share by region, 2014 & 2022
  • FIG. 31: North America FISH probe market, 2014 - 2022 (USD Million)
  • FIG. 32: U.S. FISH probe market, 2014 - 2022 (USD Million)
  • FIG. 33: Canada FISH probe market, 2014 - 2022 (USD Million)
  • FIG. 34: Europe FISH probe market, 2014 - 2022 (USD Million)
  • FIG. 35: UK FISH probe market, 2014 - 2022 (USD Million)
  • FIG. 36: Germany FISH probe market, 2014 - 2022 (USD Million)
  • FIG. 37: Asia Pacific FISH probe market, 2012 - 2022 (USD million)
  • FIG. 38: Japan FISH probe market, 2012 - 2022 (USD million)
  • FIG. 39: China FISH probe market, 2012 - 2022 (USD million)
  • FIG. 40: India FISH probe market, 2012 - 2022 (USD million)
  • FIG. 41: Latin America FISH probe market, 2012 - 2022 (USD million)
  • FIG. 42: Mexico FISH probe market, 2012 - 2022 (USD million)
  • FIG. 43: Brazil FISH probe market, 2012 - 2022 (USD million)
  • FIG. 44: MEA FISH probe market, 2012 - 2022 (USD million)
  • FIG. 45: South Africa FISH probe market, 2012 - 2022 (USD million)
Back to Top